Nephrology Hypertension

Medical Management of the Dialysis Patient: Hypocalcemia

Does this patient have hypocalcemia?

Abnormal calcium metabolism is one of the components of the laboratory abnormalities in the CKD-MBD syndrome. Decreased conversion of storage form of vitamin D, 25-hydroxyvitamin D, to calcitriol, 1,25-dihydroxyvitamin D, results in decreased gastrointestinal calcium absorption and may be accompanied by hypocalcemia without treatment.

Key elements in the history

  • Evaluate in conjunction with other laboratory components of CKD-MBD

  • Recognize that correction to total calcium for decreased albumin may need to be made and if hypocalcemia is persistent, ionized calcium should be measured

  • Ascertain history of blood transfusions

  • Consider disturbances in acid base status

  • Understand the effects of changing dialysis calcium bath on serum calcium levels

  • Understand the consequences of parathyroidectomy and pathophysiology of hungry bone syndrome

Key symptoms

  • Usually asymptomatic unless drop is severe and or acute

  • Generalized weakness, confusion

  • Perioral numbness, carpopedal spasms in hands and feet, tetany, seizures

  • Hypotension, heart failure

Key signs and physical findings

  • Chvostek's sign

  • Trousseau's sign

  • Prolonged QT interval

Other diseases or syndromes with similar appearances

  • Rule out hypoalbuminemia

  • Consider

    • Citrate-induced decrease in ionized calcium following blood transfusions

    • Acute respiratory alkalosis

    • Hungry bone syndrome

    • Sepsis

    • Acute pancreatitis

    • Rhabdomyolysis

    • Tumor lysis syndrome

    • Medications

      1. Cinacalcet

      2. Fleet's phospho-soda

      3. Bisphosphonates

      4. Denosumab

What tests to perform?

Lab testing

Which tests do I order?

  • Serum albumin, phosphate, and PTH

  • Ionized calcium if hypocalcemia is persistent

  • Magnesium levels

  • If vitamin D deficiency is being considered and repletion is to be undertaken, 25-hydroxyvitamin D levels may be obtained

  • In the intensive care unit (ICU) setting, review acid-base status

  • First, hypoalbuminemia as a cause of low total calcium levels should be ruled out with calculation of corrected calcium levels

  • Ionized calcium levels may also be useful in confirming true hypocalcemia

How often do I order test?

  • In the outpatient dialysis setting monthly routine lab tests are sufficient for monitoring and if hypocalcemia is not severe

  • For more severe and symptomatic hypocalcemia and in the inpatient setting more frequent assessments may be needed

What are the next steps?

  • Review medication history

  • Review recent medical/surgical history (transfusions, surgeries, acute intercurrent illnesses)

Overall interpretation of test results

  • Diagnosis can be confirmed by measuring ionized calcium levels

  • Prognosis depends on severity of decrease, presence of symptoms, and rate of and response to correction

How should patients with hypocalcemia be managed?

Key treatment concepts

  • Confirm diagnosis

  • Ascertain severity of symptoms

  • Correct hypomagnesemia, if present

  • Stop offending medications: cinacalcet, bisphosphonates, iron chelators

  • Oral calcium based-binders and vitamin D should correct moderate hypocalcemia

  • Severe symptomatic cases may need IV calcium

What happens to patients with hypocalcemia?

  • Hypocalcemia may exacerbate secondary hyperparathyroidism

  • Hypocalcemia has been linked with sudden cardiac death

How to utilize team care?

  • Nurses can assist in review of laboratory values and alert physicians to changes.

  • Pharmacists can review medications for potential contributing factors.

  • Dietitians can review dietary intake.

What is the evidence?

Moe, SM. "Disorders involving calcium, phosphorus, and magnesium". Prim Care. vol. 35. 2008. pp. 215-237.

(This article provides a review of mineral disorders with clinical applications to commonly detected laboratory abnormalities.)

Yusuf, B. "Hypocalcemia in a dialysis patient treated with deferasirox for iron overload". Am J Kidney Disease. vol. 52. 2008. pp. 587-590.

(This is a case report of hypocalcemia in a dialysis patient treated with deferasirox.)

Kim, ED, Parekh, RS. "Calcium and Sudden Cardiac Death in End-Stage Renal Disease". Semin Dial. vol. 28. 2015 Nov-Dec. pp. 624-35.

(This review article summarizes the evidence on the association of hypocalcemia with cardiac events in patients undergoing dialysis.)

Block, GA, Bone, HG, Fang, L, Lee, E, Padhi, D. "A single-dose study of denosumab in patients with various degrees of renal impairment". J Bone Miner Res. vol. 27. 2012. pp. 1471-9.

(This study documents the effects of denosumab on calcium levels in patients undergoing dialysis.)
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs